COLUMN GROUP III GP, LP sold 4.17M shares of TENAYA THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.38M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 2/26/2026ACC: 0001193125-26-076814
10% Owner
Since Jul 2021
-4.17M
Net shares
Net seller
$2.38M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
4.17M disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−309.23K
Price / share
$0.62
Trade value
$190.27K
% of position
15.8%
2/24/2026
1.96M→1.65M
Common Stock
Indirect
Shares
−349.21K
Price / share
$0.62
Trade value
$214.87K
% of position
15.8%
2/24/2026
2.21M→1.86M
Common Stock
Indirect
Shares
−1.65M
Price / share
$0.56
Trade value
$927.56K
% of position
New position
2/25/2026
1.65M→0.00
Common Stock
Indirect
Shares
−1.86M
Price / share
$0.56
Trade value
$1.05M
% of position
New position
2/25/2026
1.86M→0.00
Total
Net shares
−4.17M
Net value
-$2.38M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/24/2026 | S · Sale | −309.23K | $0.62 | $190.27K | 15.8% | 1.96M | 1.65M |
| Common Stock Indirect | 2/24/2026 | S · Sale | −349.21K | $0.62 | $214.87K | 15.8% | 2.21M | 1.86M |
| Common Stock Indirect | 2/25/2026 | S · Sale | −1.65M | $0.56 | $927.56K | New position | 1.65M | 0.00 |
| Common Stock Indirect | 2/25/2026 | S · Sale | −1.86M | $0.56 | $1.05M | New position | 1.86M | 0.00 |
| Total | −4.17M | -$2.38M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned49.31M
Total
49.31M indirect49.31M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 49.31M | Indirect |
| Total | 49.31M | 49.31M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported